Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Clarivate Analytics acquires Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry

Posted On: 2020-01-18 09:46:11

Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has signed a definitive agreement to acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited ("PEL", NSE: PEL, BSE: 500302), part of global business conglomerate Piramal Group. The $950 million purchase price-approximately 12x trailing DRG Adjusted EBITDA, taking into account acquisition cost synergies but not revenue synergies-includes $900 million in cash and approximately $50 million in Clarivate ordinary shares to be issued following the one-year anniversary of closing. The acquisition is expected to be accretive to Clarivate earnings in 2020.

DRG specializes in enabling the world's leading pharma, biotech and medical technology companies to achieve commercial success in complex health markets with the creation of effective patient-centric commercial strategies. Together, DRG and Clarivate will be well-positioned in the $19 billion Life Sciences analytics market, which currently is enjoying double-digit growth, to support customers across the entire drug, device and medical technology lifecycle from research to outcome. The combined business will offer a one-stop shop for Life Sciences customers, helping them to improve the commercialization of life-changing therapies.

Jerre Stead, Executive Chairman and CEO, Clarivate Analytics: "This is a milestone acquisition which doubles the size of our Life Sciences business, is accretive to our 2020 earnings, and sets us up to become an essential, end-to-end, industry-leading data and analytics provider to the highly attractive Life Sciences ecosystem. We expect the acquisition of DRG to increase Clarivate's total company revenue by 20%, deliver approximately $77 million in annual Adjusted EBITDA before the pursuit of any revenue synergies, and drive DRG's Adjusted EBITDA margins towards Clarivate's total company target of greater than 40%.

"Both companies have a great heritage-built on talented people with deep industry subject matter and technical expertise. Together, we look forward to unlocking the tremendous potential of a unified team."

Ajay Piramal, Chairman Piramal Group: "We are pleased to have grown DRG's market leadership over the last few years and believe that through this combination, Clarivate, with its size and scale, is well positioned to further accelerate DRG's growth potential. This transaction demonstrates our continued commitment to create sustained long-term value for all stakeholders.

"Along with the ongoing equity capital raise in PEL, this transaction not only further strengthens the company's balance sheet but also marks another step towards significantly unlocking value in future."

Mukhtar Ahmed, President, Science Group, Clarivate Analytics: "The addition of DRG's services and solutions to our portfolio supports our focus on creating exceptional customer value through delivering highly specialized analytics and expert insights and a wider range of Life Sciences solutions that help solve our customers' most difficult challenges when discovering, developing and commercializing new drugs, medical devices and technologies. The acquisition also means that by combining expertise, data and technologies, Clarivate will be able to pursue significant growth opportunities through new product development and deeper market penetration driven by offering our customers a broader portfolio of tools and services."

Vivek Sharma, CEO, DRG: "I am excited for this acquisition as it creates an even more powerful platform for DRG's AI and analytics-enabled solutions to support our customers in their quest to improve patient health outcomes. This new and expanded platform will further empower our employees to continue their focus on customer centricity and collaborative innovation with our customers."

DRG's current CEO, Vivek Sharma, will depart the company following the completion of the transaction, when the business will join the Science Group at Clarivate Analytics, under the stewardship of Mukhtar Ahmed, President-Science Group. This Product Group includes both the Cortellis™ suite of Life Science intelligence solutions and Web of Science, the world's largest publisher-neutral citation index and research intelligence platform.

Numerous Strategic Benefits to Drive Future Growth

- Complementary Fit with Clarivate Life Sciences: Combining the expertise, data and technologies of DRG with Clarivate will help customers make smarter and faster evidence-based decisions to boost clinical and commercial success. Clarivate's Life Sciences products, including Cortellis, focus on innovation covering the front-end of Life Science development, encompassing pre-clinical and clinical development, regulatory review and business development, while DRG has largely focused on the delivery of essential solutions for the successful commercialization of pharmaceutical products and medical devices & technologies.

- Creates a Top Data and Analytics Provider in Life Sciences: DRG's and Clarivate's complementary solutions will better position the combined organization in a market that favors tech-enabled players with end-to-end capabilities and broad and proprietary data sets. Clarivate's enhanced Life Sciences offering will be well-positioned to support customers across the entire drug, device and medical technology lifecycles.

- Sales Opportunities to Drive Growth: Leveraging the expertise, content and technologies of both Clarivate and DRG will create significant revenue growth opportunities through new product development and support deeper market penetration, driven by offering each company's customer base the benefits of a more comprehensive suite of products.

Financially Compelling Transaction

- Accretive to Clarivate's Earnings per Share: The transaction is expected to be accretive to Clarivate's earnings per share in 2020.

- Growing Revenue and EBITDA Business with Significant Cost Savings Opportunities: In 2019, DRG generated $207 million of revenue, with 9% organic growth, and $47 million of Adjusted EBITDA before the impact of acquisition cost synergies. Clarivate expects to achieve cost synergies of approximately $30 million within the first 18 months after the transaction closes, which in addition to revenue synergies, is expected to drive DRG's Adjusted EBITDA growth and expand its Adjusted EBITDA margin towards the 40% range.

- Strong Free Cash Flow Generation and Funding Plan Supports Deleveraging: Clarivate remains committed to managing its balance sheet and its go-forward capital structure. The company plans to fund the transaction with an optimal mix of debt and equity capital proceeds.

Financing and Approvals

In connection with the transaction, Clarivate has secured a backstop of $900 million fully committed bridge facility from Citi and Goldman Sachs & Co. LLC. Clarivate expects to obtain long-term financing with proceeds from debt and equity capital markets before the closing of the transaction.

The transaction is expected to close within the first quarter of 2020, subject to the satisfaction of customary closing conditions and regulatory approvals, including approval by PEL's shareholders.

Shares of PIRAMAL ENTERPRISES LTD. was last trading in BSE at Rs.1627.05 as compared to the previous close of Rs. 1546.95. The total number of shares traded during the day was 144728 in over 8627 trades.

The stock hit an intraday high of Rs. 1655 and intraday low of 1551.55. The net turnover during the day was Rs. 233882785.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Reliance consolidates media and distribution businesses under Network18

Huhtamaki PPL Ltd Q4 net profit surges to Rs. 68.18 crore

CARE downgrades rating of Vodafone Idea Ltd to CARE BB-

Tata Power prepares for #FutureReady consumers

GMR Energy Limited to divest entire stake in GMR Kamalanga Energy Limited to JSW Energy Limited

JSW Steel Ltd emerges preferred bidder for 3 iron ore mines in Odisha

Vodafone Idea Limited updates on Supreme Court Judgment in AGR matter

Kisan Mouldings Ltd enters into MOU with PIL Italica Lifestyle Ltd

TTSL and TTML makes payment of Rs. 2197 crores to DoT

KPI Global Infrastructure bags order for executing solar power project of 900KW capacity

Dream Company to Work for in Real Estate - Embassy Group

JSW Energy Ltd to acquire 1050 MW power project from GMR Kamalanga Energy Ltd

Firstsource Solutions Ltd board approves interim dividend of Rs.2.50

Orissa Minerals Development Company Ltd updates on enhancement of production

Pil Italica Lifestyle Ltd signs MOU with Kisan Mouldings Limited

ICL makes a strong debut lists at a 4.00% premium

Nitin Thakur joins Jindal Stainless as Head of Learning and Development

Alphageo (India) Ltd receives award of contracts from Oil India Limited

Aurionpro's Transaction Banking platform - iCashpro+ emerges winner at the prestigious Finnoviti & Technoviti Awards 2020

Bharti Airtel Ltd has paid Rs. 10,000 crores of AGR dues

Shri Manoj Jain takes charge as Chairman & Managing Director, GAIL

Fino Payments Bank selects Seqrite mSuite to power its Workforce Mobility

Cyient Inaugurates Wire Harness Lab for Production and Prototyping in its Peoria Office

Bhageria Industries Ltd commences commercial production of Sulphuric Acid plant

Sambhaav Media Limited commences FM Radio Station at Kathua (Jammu & Kashmir)- 91.1 MHz

Junction Fabrics and Apparels Ltd Board approves 1:2 Bonus Issue

Kaira Can Co. Ltd board declares interim dividend of Rs. 9 for 2019-20

TCS Named a Leader and Star Performer in Life & Annuities Insurance Application and Digital Services by Everest Group

Clariant Chemicals nine monthly sales grew by 10.1%

U.S. FDA completes inspection of Lupin's Aurangabad facility with Zero observation

Tata Elxsi IoT software powers Tata Motors Connected Vehicle Platform

Morepen Labs' net profit rises by 21% in Q3 FY 2019-20 led by a stable performance in all business segments

Godrej Properties to purchase 26 acres in central Delhi in 2020's largest land transaction

IndiGo to connect Dammam with Delhi w.e.f. March 10, 2020

Union Bank of India bags prestigious IBA Award

Elpro Join Hands with Shiksha Seva Foundation to Empower Girl Child

CREDAI and SBI organise three day Double Assurance Realty Expo

HCG Hospital Redefines cancer diagnostics with the first Digital PET CT scanner in Karnataka

Varroc Showcases the Roadmap for the Future of Mobility at Auto Components Expo

IndiGo now connects Mumbai-Kathmandu and Bangalore-Jeddah

Airtel and Nokia to collaborate on Industry 4.0 applications for enterprises

IndiGo launches Hindi website to strengthen its regional reach

Reliance Infrastructure Ltd Q3 FY20 consolidated PAT up 18% at Rs. 346 crores

Glenmark's consolidated Net Profit rises by 64% to Rs. 1,908.39 Mn. in Q3 FY 2019-20

Reliance Power Ltd Q3 FY20 PAT at Rs. 49 crore

Panacea Biotec Ltd announces financial results for period ended Dec 31, 2019

Nila Infrastructures Ltd reports earnings for Q3 FY2020

Shyam Century Ferrous Limited updates on credit rating

Akme Star Housing Finance Ltd opens branch in Chennai

Ashoka Buildcon Ltd receives LOA from NHAI for Tumkur-Shivamogga road project







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019